EPISODE · Nov 4, 2025 · 7 MIN
BIO-Europe 2025: Spain based ARTHEx Biotech is a European player in the DM1 space, and believes its microRNA strategy offers a dual benefit that it says is unique to the field
from BiotechTV - News · host BiotechTV
CEO Frédéric Legros walks us through the science and explains why he believes ARTHEx has a unique approach compared to others we have seen in the field. The company raised an $87M series B in September.
Embed this episode
Ready to play
BIO-Europe 2025: Spain based ARTHEx Biotech is a European player in the DM1 space, and believes its microRNA strategy offers a dual benefit that it says is unique to the field
No transcript for this episode yet
Similar Episodes
Mar 16, 2026 ·11m
Similar Podcasts
No similar podcasts found.